<?xml version='1.0' encoding='utf-8'?>
<document id="31060007"><sentence text="Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation."><entity charOffset="18-25" id="DDI-PubMed.31060007.s1.e0" text="aspirin" /></sentence><sentence text="Both aspirin and vicagrel are effective antiplatelet drugs, with the potential for concomitant use as another dual-antiplatelet therapy for the prevention of recurrent thrombotic or ischemic events"><entity charOffset="5-12" id="DDI-PubMed.31060007.s2.e0" text="aspirin" /></sentence><sentence text=" Because they both are the substrates of carboxylesterase 2 (CES2), aspirin attenuated the metabolic activation of and platelet response to vicagrel in mice treated with the two drugs concomitantly"><entity charOffset="68-75" id="DDI-PubMed.31060007.s3.e0" text="aspirin" /></sentence><sentence text=" In this study, we sought to clarify whether vicagrel could affect platelet responses to aspirin and their underlying mechanisms"><entity charOffset="89-96" id="DDI-PubMed.31060007.s4.e0" text="aspirin" /></sentence><sentence text=" Plasma levels of aspirin and salicylic acid were determined by liquid chromatography-tandem mass spectrometry, inhibition of arachidonic acid (AA)-induced whole-blood platelet aggregation by aspirin was assessed with an aggregometer, and their antithrombotic effects were evaluated by arteriovenous shunt thrombosis model"><entity charOffset="18-25" id="DDI-PubMed.31060007.s5.e0" text="aspirin" /><entity charOffset="30-44" id="DDI-PubMed.31060007.s5.e1" text="salicylic acid" /><entity charOffset="126-142" id="DDI-PubMed.31060007.s5.e2" text="arachidonic acid" /><entity charOffset="192-199" id="DDI-PubMed.31060007.s5.e3" text="aspirin" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e0" e2="DDI-PubMed.31060007.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e0" e2="DDI-PubMed.31060007.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e0" e2="DDI-PubMed.31060007.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e0" e2="DDI-PubMed.31060007.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e1" e2="DDI-PubMed.31060007.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e1" e2="DDI-PubMed.31060007.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e1" e2="DDI-PubMed.31060007.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e2" e2="DDI-PubMed.31060007.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31060007.s5.e2" e2="DDI-PubMed.31060007.s5.e3" /></sentence><sentence text=" The results showed that concomitant use of vicagrel (5, 10, or 20 mg/kg) led to an average of 55% and 77% increases in systemic exposure of aspirin (Cmax and AUC0-t) and 2"><entity charOffset="141-148" id="DDI-PubMed.31060007.s6.e0" text="aspirin" /></sentence><sentence text="8-fold increase in suppression of AA-induced platelet aggregation in mice when compared with use of aspirin alone"><entity charOffset="100-107" id="DDI-PubMed.31060007.s7.e0" text="aspirin" /></sentence><sentence text=" In the rat thrombus formation model, vicagrel (1 mg/kg) enhanced inhibition of thrombosis formation by aspirin (5 mg/kg), but not vice versa"><entity charOffset="104-111" id="DDI-PubMed.31060007.s8.e0" text="aspirin" /></sentence><sentence text=" We conclude that vicagrel increases platelet responses to aspirin and also enhances inhibition of thrombus formation of aspirin due to decreased CES2-catalyzed aspirin inactivation in rodents, and that an integrated net effect on thrombus formation in vivo is superior to inhibition of AA- or ADP-induced platelet aggregation ex vivo by either of the two drugs if taken concomitantly"><entity charOffset="59-66" id="DDI-PubMed.31060007.s9.e0" text="aspirin" /><entity charOffset="121-128" id="DDI-PubMed.31060007.s9.e1" text="aspirin" /><entity charOffset="161-168" id="DDI-PubMed.31060007.s9.e2" text="aspirin" /><pair ddi="false" e1="DDI-PubMed.31060007.s9.e0" e2="DDI-PubMed.31060007.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31060007.s9.e0" e2="DDI-PubMed.31060007.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31060007.s9.e0" e2="DDI-PubMed.31060007.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31060007.s9.e1" e2="DDI-PubMed.31060007.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31060007.s9.e1" e2="DDI-PubMed.31060007.s9.e2" /></sentence><sentence text="" /></document>